A Houston company's technology will help space operators predict coronal mass ejections. Photo via nasa.gov

Following a rebrand, a Houston tech startup has secured a NASA contract for space weather technology.

Dauntless XR received a contract from NASA to advance its spatial computing platform, Aura. The technology uses satellite sensor data and mixed reality to help space operators with weather forecasting, including solar activity.

The company, which was founded by Lori-Lee Elliott as Future Sight AR in 2018 to focus on industrial construction, made a pivot to the space and defense industries and rebranded last year.

"We are in an incredibly interesting stage of space exploration, between record-breaking numbers of satellite launches, missions to the moon and Mars, and even returning asteroid samples to Earth," says Elliott, who serves as CEO, in the release. "With space weather, we are presented with an opportunity to make incredibly complex data easily accessible and provide a platform for innovation — and collaboration — for the space economy and space exploration."

The company is tasked with an extended reality space weather application. Per the release, the app will first be available on the Apple Vision Pro and the Meta Quest devices.

"Our first release will include a special edition of our Aura application with a 3D immersive experience visualizing coronal mass ejections, or CMEs, coming off the sun," the company explains in a blog post. "When a CME hits Earth, it produces auroras, but can also cause power outages, knock out radio signals & GPS, and interfere with rocket launches. As the space economy grows and more people use space data, we hope that our apps make that data easy to access and understand."

The company has also received $1.5 million in United States Air Force contracts. This included two SBIR II contracts that "focused on mixed reality assisted workflows, training and mission planning," according to Dauntless XR. Elliott is based in Houston and the company has offices in Texas, Georgia, Florida, and Hawaii.

Lori-Lee Elliott founded Dauntless XR. Photo via LinkedIn

Grab a lantern and enter an epic journey. Photo courtesy of Department of Wonder

Immersive mixed-reality exhibit lights up Houston-area suburb

new tech-enabled experience

Immersive experiences are all the rage; Houston already boasts two Van Gogh experiences (including yoga) and a Frida Kahlo event on the way.

Now, a new entertainment concept offering up exploration and discovery will open its first Houston location in Sugar Land in early 2022. But rather than passive viewing, this immersive activity sets the visitors on a quest in both physical and digital worlds.

Department of Wonder is a new, 10,000-square-foot venue that stages an immersive, mixed-reality fantasy in Sugar Land’s Town Square (2180 Lone Star Dr.). Guests wield a light-gathering lantern and are charged with unraveling stories and solving puzzles amidst a universe of interactive experiences and colorful characters, per a release.

This totally lit experience was forged by an acclaimed creative team of storytellers; recognizable names include Academy Award-winning director Brandon Oldenburg and Emmy Award-winning director Limbert Fabian.

“It’s like stepping inside a film as the main character and being bestowed an epic quest,” said Oldenburg in a statement. “We think it’s the next evolution of location-based entertainment.”

The introduction of the Department of Wonder will coincide with the completion of significant streetscape improvements to the 32-acre Sugar Land Town Square. The bustling shopping, dining, and community hub is in the midst of a major set of upgrades to retail tenancy, event programming, and the physical environment.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”